Osilodrostat (LCI699)
CAS: 928134-65-0
Ref. 3D-DMB13465
| 1mg | 63.00 € | ||
| 2mg | 97.00 € | ||
| 5mg | 138.00 € | ||
| 10mg | 194.00 € | ||
| 25mg | 309.00 € |
Product Information
Osilodrostat is a drug that inhibits the activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). It inhibits the conversion of cortisol to cortisone, which leads to an increase in cortisol levels. This drug has been shown to be effective in treating adrenocortical carcinoma by inhibiting the production of cortisol. Osilodrostat has a long half-life and may have therapeutic benefits in patients with congestive heart failure or renal disease. The drug also has anti-inflammatory properties, which can reduce the production of proinflammatory cytokines such as epidermal growth factor and aldosterone.
Chemical properties
Technical inquiry about: 3D-DMB13465 Osilodrostat (LCI699)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
